Rachmawati, Annisa (2024) GAMBARAN KADAR SGOT DAN SGPT PADA PENDERITA TUBERCULOSIS DALAM MASA PENGOBATAN 6 BULANDI WILAYAH PUSKESMAS TUNGGAKJATI TAHUN 2024. Diploma thesis, Sekolah Tinggi Analis Bakti Asih.
![[thumbnail of BAB I]](https://repository.staba.ac.id/style/images/fileicons/text.png "BAB I")
Text (BAB I)
annisa-13-18.pdf
Download (581kB)
Text (BAB II)
annisa-19-30.pdf
Download (1MB)
Text (BAB III)
annisa-31-36.pdf
Download (674kB)
Text (BAB IV)
annisa-37-43.pdf
Restricted to Registered users only
Download (542kB)
Text (BAB V)
annisa-44-45.pdf
Download (502kB)
Text (DAFTAR PUSTAKA)
annisa-46-47.pdf
Download (435kB)
Abstract
Tuberculosis (TB or TB) is an infectious disease caused by the bacteria Mycobacterium tuberculosis. Based on data from WHO, Asia is the region with the largest number of new TB cases, while Southeast Asia is the region with the second largest number of new cases and deaths due to TB. Liver function abnormalities are the most common side effect of anti-tuberculosis drug (OAT) regimens. Two types of enzymes that are often associated with liver cell damage are SGOT and SGPT. This study aims to determine the description of SGOT and SGPT levels in tuberculosis sufferers during the 6 month treatment period in the Tunggakjati Community Health Center area. This research was conducted in the Tunggakjati Community Health Center area in April 2024-finish. This type of research is descriptive, which aims to provide an interpretation of the results regarding SGOT and SGPT levels in tuberculosis sufferers during the 6 month treatment period. The results of the research showed that the results of examining SGOT and SGPT levels in 10 samples were that there were 6 (60%) samples that did not experience an increase or were normal and there were 4 (40%) samples that experienced an increase or were abnormal.
Key words: Serum Glutamic Pyruvic Transaminase (SGPT) Treatment, Tuberculosis.
| Item Type: | Thesis (Diploma) |
|---|---|
| Additional Information: | Tuberkulosis (TB atau TBC) adalah penyakit menular yang disebabkan oleh bakteri Mycobacterium tuberculosis.Berdasarkan data dari WHO , Asia merupakan wilayah dengan jumlah kasus TB baru terbesar, sedangkan Asia Tenggara merupakan wilayah dengan jumlah kedua terbesar kasus baru dan kematian akibat TB. Abnormalitas fungsi hati merupakan efek samping tersering pemberian regimen obat anti tuberkulosis (OAT). Dua macam enzim yang sering dihubungkan dengan kerusakan sel hati yaituSGOTdan SGPT. Penelitian ini bertujuan untuk mengetahui Gambaran Kadar SGOT dan SGPT Pada Penderita Tuberculosis Dalam Masa Pengobatan 6 Bulan di Wilayah Puskesmas Tunggakjati. Penelitian ini dilakukan di Wilayah Puskesmas Tunggakjati pada bulan April 2024-selesai. Jenis penelitian ini adalah deskriptif, yang bertujuan untuk memberikan interprestasi hasil tentang kadar SGOT dan SGPT Pada penderita tuberculosis dalam masa pengobatan 6bulan. Hasil penelitian menunjukkan bahwa hasil pemeriksaan kadar SGOT dan SGPT pada 10 sampel yaitu terdapat 6 (60%) sampel yang tidak mengalami peningkatan atau normal dan terdapat 4 (40%) sampel yang mengalami peningkatan atau abnormal. Kata kunci : Pengobatan Serum Glutamic Pyruvic Transaminase (SGPT) |
| Subjects: | Program Studi > Analis Kesehatan > Bakteriologi Program Studi > Analis Kesehatan > Kimia Klinik Program Studi > Analis Kesehatan |
| Divisions: | Analis Kesehatan > Kimia Klinik |
| Depositing User: | Admin Repo |
| Date Deposited: | 05 Feb 2026 07:27 |
| Last Modified: | 05 Feb 2026 07:27 |
| URI: | https://repository.staba.ac.id/id/eprint/36 |
Actions (login required)
- View Item